ClinicalTrials.Veeva

Menu

TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients (TRADE HF)

Boston Scientific logo

Boston Scientific

Status and phase

Completed
Phase 4

Conditions

Heart Failure, Congestive

Treatments

Device: Dual (atrial and ventricular) implantable defibrillator

Study type

Interventional

Funder types

Industry

Identifiers

NCT00345592
2005_TH

Details and patient eligibility

About

Demonstrate the efficacy of the device-based managed therapy to treat atrial tachycardia and fibrillation (AT/AF) in patients with CHF indication for implant of a CRT defibrillator and to demonstrate the advantage of automatic electrical therapy of atrial arrhythmias compared to an in-hospital approach for treatment of symptomatic AT/AF.

Enrollment

420 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic symptomatic HF despite stable, optimal drug therapy
  • indication for a cardiac resynchronisation device with defibrillator backup according to current guidelines
  • patients implanted with cardiac resynchronization device with dual (atrial and ventricular) defibrillation capabilities

Exclusion criteria

  • Chronic atrial fibrillation
  • Valvular disease
  • patients who underwent or are planned for ablation of atrial fibrillation
  • cerebral vascular accident/transient ischemic attack within 12 months from implant which lead to relevant impairment
  • preexisting unipolar pacemaker

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

420 participants in 2 patient groups

Device managed arm
Experimental group
Description:
Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.
Treatment:
Device: Dual (atrial and ventricular) implantable defibrillator
Device: Dual (atrial and ventricular) implantable defibrillator
Device: Dual (atrial and ventricular) implantable defibrillator
Traditional arm
Active Comparator group
Description:
Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.
Treatment:
Device: Dual (atrial and ventricular) implantable defibrillator
Device: Dual (atrial and ventricular) implantable defibrillator
Device: Dual (atrial and ventricular) implantable defibrillator

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems